Vitamin K is a nutrient that helps blood clot normally. Newborn babies are born with very low levels of vitamin K, which can increase the risk of serious bleeding.
Vitamin K for newborns is given soon after birth to prevent vitamin K deficiency bleeding, also called VKDB. This bleeding can happen in the first days of life or later in infancy, and it may affect the brain or other organs.
In the United States, vitamin K is usually given as an injection into the muscle shortly after birth. This is the standard method because it provides strong protection with one dose.
Why it is given
Vitamin K is indicated for newborns to prevent and treat hemorrhagic disease of the newborn, also known as vitamin K deficiency bleeding.
It may be recommended for all newborns because babies naturally have low vitamin K levels at birth. This can happen because only small amounts of vitamin K pass through the placenta during pregnancy, and newborns do not yet have enough bacteria in the gut to make vitamin K. Breast milk also contains relatively low amounts of vitamin K.
Without vitamin K prophylaxis, some babies can develop vitamin K deficiency bleeding. This may cause bleeding from the umbilical cord, skin, nose, stomach, intestines, or after procedures, and severe cases can involve bleeding in the brain.
How it is administered
In the United States, vitamin K is most often given as phytonadione by intramuscular injection. The usual FDA-labeled dose for newborns is 0.5 to 1 mg injected into the muscle within 1 hour after birth.
Other professional guidance also supports giving 0.5 to 1 mg of vitamin K by intramuscular injection within the first hours after birth. This single injection helps protect against early, classic, and late forms of vitamin K deficiency bleeding.
Oral vitamin K may be used in some countries or when the injection is refused. However, oral vitamin K usually requires more than one dose, and protection against late vitamin K deficiency bleeding may be less reliable if doses are missed.
Some international regimens use repeated oral doses, such as a dose at birth followed by additional doses over the next weeks. Oral vitamin K is generally not advised for some high-risk newborns, especially when there is concern about poor absorption.
Possible side effects
Vitamin K is generally considered safe when given to newborns at the recommended dose.
Possible side effects may include pain, swelling, or redness where the injection is given. Rarely, allergic-type reactions may occur.
The FDA label for injectable phytonadione includes warnings about serious reactions with IV use, especially when given too quickly. For routine newborn prevention, vitamin K is usually given into the muscle, not by rapid IV injection.
Some older concerns suggested a possible link between vitamin K injections and childhood cancer. Later studies reviewed by professional sources did not support this link, and current guidance continues to support vitamin K injection for newborns.
Contraindications for use
Vitamin K should not be used in babies with known hypersensitivity to phytonadione or any component of the injection.
Extra caution may be needed when deciding the route of administration in babies with certain medical problems. For example, oral vitamin K may not be appropriate for babies who are at higher risk of vitamin K deficiency bleeding or who may not absorb vitamin K well.